AMRZ AMRZ
Company Profile ↓Company Overview
AMRZ (AMRZ) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 11.3% per year over the last five years.
Operating margin of 16.1% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $11.81B (+0.9% YoY); net profit $1.19B.
- Trailing 12 Months Year-on-year growth — revenue +0.9%, earnings -7.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 0.6%, profit CAGR 11.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 0.59% |
| 1 Year: | 0.95% |
Compounded Profit Growth
| 5 Years: | 11.33% |
| 1 Year: | -6.99% |
Stock Price Performance
| 1 Year: | +5.17% |
| 6 Months: | -1.10% |
| 3 Months: | -0.71% |
| 1 Month: | +3.81% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)57.99 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 11.3% over 5 years.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | 3.24B | 3.45B | 2.08B | 3.22B | 3.67B | 2.18B |
| Gross Profit | 979.00M | 1.04B | 222.00M | 966.00M | 1.09B | 211.00M |
| Operating Income | 754.00M | 844.00M | -16.00M | 669.00M | 778.00M | -76.00M |
| Net Income | 474.00M | 553.00M | -87.00M | 429.00M | 545.00M | -116.00M |
| Diluted EPS | 0.86 | 1.00 | -0.16 | 0.78 | 0.98 | -0.21 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 11.68B | 11.70B | 11.81B |
| Gross Profit | 2.77B | 3.07B | 3.03B |
| Operating Income | 1.89B | 2.19B | 1.91B |
| Net Income | 956.00M | 1.27B | 1.19B |
| Diluted EPS | 1.73 | 2.30 | 2.14 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | - | - | 23.80B | 24.25B |
| Total Equity | 8.21B | 9.20B | 9.91B | 13.26B |
| Cash & Equivalents | - | - | 1.58B | 1.92B |
| Total Liabilities | - | - | 13.89B | 10.99B |
| Current Liabilities | - | - | 2.55B | 2.86B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | 2.04B | 2.28B | 2.21B |
| Investing Cash Flow | -2.02B | -1.21B | -361.00M |
| Financing Cash Flow | 734.00M | -537.00M | -1.55B |
| Capital Expenditure | -630.00M | -642.00M | -788.00M |
| Free Cash Flow | 1.41B | 1.64B | 1.42B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | 23.7% | 26.2% | 25.7% |
| Operating Margin % | 16.2% | 18.8% | 16.1% |
| Net Margin % | 8.2% | 10.9% | 10.0% |
| ROE % | 10.4% | 12.8% | 8.9% |
| ROCE % | - | 10.3% | 8.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AMRZ
Amrize Stock (AMRZ) Opinions on Upcoming Earnings Release - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPQU9mLUlrVVlnejdLenRhb2kzMk5GWkRCSWI2UHQ4cFJoMnJLMktPcjU0RHYzRVM4YThrc1daQ1ctXy1yeDZzaDhfVmNTSWtnR2ZWenp3Y1ZaTDJ0bUdMWlZuVGQ1bE5PeHdkb0R6YTE3ZkFBQVNsUTZ1eWZQTUVUTENUOW5rTVliaUJZNU…
Amrize Ltd (AMRZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOejYyYTFpbG85VHk2WkdtTDlPNUlOVndxRzhuSDNKWGlyVU5HYjFIeFdZcTNvTlBTSFd3SEM3RUU4ZFRMMjJfTnJFRk83UFBGMDAtZnI5V3dxSWJGOHQ1OU0wcHZELWo2emNlRTVFUjRsdXFodVVud3M1UXhzeVd6T2xwdkRQMWFpRmZZen…
AMRZ - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE1QY1RsQjFkZEttOWF1TGROS3gtWndPdU1WaGs5ekVKQ05PUzNjZUxNamZIYXZETkVZRnRFQV96NnBQRHhhZWc?oc=5" target="_blank">AMRZ</a> <font color="#6f6f6f">Finviz</font>…
Amrize: Strong Materials Momentum Can Offset Roofing Weakness (NYSE:AMRZ) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQVWFEM3FuLUwtbEhkOHozMWRMQU9zY0dIaExTVS1qWFd5UDVQQVUxM25YVWl5V3lGNEVCcm9peWZwbXVCUm5QMlMzOGs0V0lwTkJJcjh2eE9pQUpERGNpM1F1Y1NVWmI3RkU1LXV3cHpUeVJfYThCcGtObFZfeDVYeGNYODNGTm1wTHBTY3…
AMRZ Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE4tRUl2UDZpRVR5ZUg0VWR5SHlxWGlzUjNRaldsbldhSkhfeEFiRDJ5TmM4NEVQYTdFaXBVY25zcERaSUtKY25tb2xabnVHZ2xsRFJSOWJDcmRNMkpNc2R0Z0N0VlhWa2xleTZTN080Y2w3bWswUl93?oc=5" target="_blank">AMRZ Fo…
Amrize investors greenlight two dividends and 2 new directors - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOM2c4WHdNSTRWTUN0d0MzaEJGTnBxbXd2WkpWdV9hNFFEb3RHY3BJeEVxLVg3N2JKRmtSSzA2QUJjTjhQYVpNaXc0UEdRS3lHcU9PeVJFS1k4Z1NPTlRzOERoSGJWOFVTNnY2djdSWnpOeVBUZXJHMlFrZER0NXF4WXpmUk1qZXk1UjVROG…
AMRZ — Frequently Asked Questions
What is the current share price of AMRZ?
As of 2026-08-05 17:25 PDT, AMRZ trades at $52.88 on NASDAQ/NYSE. Its 52-week range is $46.19 to $65.21.
What is the P/E ratio of AMRZ?
AMRZ trades at a trailing price-to-earnings (P/E) ratio of 24.71.
What is the return on equity (ROE) of AMRZ?
AMRZ has a return on equity (ROE) of 8.94%. Its return on capital employed (ROCE) is 8.91%.
Is AMRZ a good stock to buy?
This page provides a data-driven analysis of AMRZ, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.